Alaunos Therapeutics (TCRT) Amortization of Deferred Charges (2021 - 2023)
Alaunos Therapeutics' (TCRT) quarterly Amortization of Deferred Charges came in at $867000.0 in Q2 2023, up 318.84% YoY from $207000.0 in Q2 2022, and up 83.69% on a QoQ basis from $472000.0 in Q1 2023.
Alaunos Therapeutics (TCRT) Amortization of Deferred Charges (2021 - 2023) Analysis & Trends
Alaunos Therapeutics (TCRT) has 3 years of Amortization of Deferred Charges data on file, last reported at $867000.0 in Q2 2023.
- Quarterly Amortization of Deferred Charges rose 318.84% year-over-year to $867000.0 in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $867000.0 (down 30.92% YoY) and the FY2023 annual result came in at $1.3 million, up 36.49% from the prior year.
- Amortization of Deferred Charges grew to $867000.0 in Q2 2023, from $472000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $867000.0 in Q2 2023 to a low of $148000.0 in Q3 2021.
- A 3-year average of $337875.0 and a median of $232000.0 in 2021 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges surged 47.66% — and 2023, when it jumped 318.84%.
- Tracing TCRT's Amortization of Deferred Charges over 3 years: stood at $235000.0 in 2021, then surged by 47.66% to $347000.0 in 2022, then surged by 149.86% to $867000.0 in 2023.
- The last three Amortization of Deferred Charges figures came in at $867000.0 (Q2 2023), $472000.0 (Q1 2023), and $347000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 867,000.00 |
| Jun 30, 2023 | 867,000.00 |
| Mar 31, 2023 | 472,000.00 |
| Mar 31, 2023 | 472,000.00 |
| Dec 31, 2022 | 347,000.00 |
| Dec 31, 2022 | 347,000.00 |
| Sep 30, 2022 | 229,000.00 |
| Sep 30, 2022 | 229,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Jun 30, 2022 | 207,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Sep 30, 2021 | 148,000.00 |
| Sep 30, 2021 | 148,000.00 |